Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Malignant Melanoma

  Free Subscription


01.07.2019

1 Ann Surg Oncol
1 Br J Dermatol
3 Clin Cancer Res
1 Cutis
2 J Am Acad Dermatol
1 J Cell Physiol
2 J Invest Dermatol
1 J Surg Oncol
4 Melanoma Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. IPENBURG NA, Thompson JF, Uren RF, Chung D, et al
    Focused Ultrasound Surveillance of Lymph Nodes Following Lymphoscintigraphy Without Sentinel Node Biopsy: A Useful and Safe Strategy in Elderly or Frail Melanoma Patients.
    Ann Surg Oncol. 2019 Jun 25. pii: 10.1245/s10434-019-07505.
    PubMed     Text format     Abstract available


    Br J Dermatol

  2. KIM HS, Kim HJ, Hong ES, Kim KB, et al
    The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea.
    Br J Dermatol. 2019 Jun 24. doi: 10.1111/bjd.18247.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  3. FAIAO-FLORES F, Emmons MF, Durante MA, Kinose F, et al
    HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma.
    Clin Cancer Res. 2019 Jun 21. pii: 1078-0432.CCR-18-3382.
    PubMed     Text format     Abstract available

  4. ANBUNATHAN H, Verstraten R, Singh AD, Harbour JW, et al
    Integrative copy number analysis of uveal melanoma reveals novel candidate genes involved in tumorigenesis including a tumor suppressor role for PHF10/BAF45a.
    Clin Cancer Res. 2019 Jun 21. pii: 1078-0432.CCR-18-3052.
    PubMed     Text format     Abstract available

  5. RODRIGUES M, Mobuchon L, Houy A, Alsafadi S, et al
    Evolutionary routes in metastatic uveal melanomas depend on MBD4 alterations.
    Clin Cancer Res. 2019 Jun 21. pii: 1078-0432.CCR-19-1215.
    PubMed     Text format     Abstract available


    Cutis

  6. LYONS AB, Mitchell DA, Moy RL
    Topical chemotherapy for numerous superficial basal cell carcinomas years after isolated limb perfusion for melanoma.
    Cutis. 2019;103:298-299.
    PubMed     Text format    


    J Am Acad Dermatol

  7. NAVARRETE-DECHENT C, Aleissa S, Ariyan C, Busam KJ, et al
    Melanoma in situ margins: 9 mm for ALL cases may not be appropriate.
    J Am Acad Dermatol. 2019 Jun 21. pii: S0190-9622(19)31022.
    PubMed     Text format    

  8. WEI EX, Li X, Nan H
    Having a first-degree relative with melanoma increases lifetime risk of melanoma, squamous cell carcinoma, and basal cell carcinoma.
    J Am Acad Dermatol. 2019 Jun 20. pii: S0190-9622(19)30639.
    PubMed     Text format     Abstract available


    J Cell Physiol

  9. YANG S, Liu T, Nan H, Wang Y, et al
    Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of cutaneous melanoma.
    J Cell Physiol. 2019 Jun 25. doi: 10.1002/jcp.29018.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  10. AIRA LE, Debes GF
    B Cells and Melanoma Pathogenesis.
    J Invest Dermatol. 2019;139:1422-1424.
    PubMed     Text format     Abstract available

  11. VOGEL FCE, Bordag N, Zugner E, Trajkovic-Arsic M, et al
    Targeting the H3K4 demethylase KDM5B reprograms the metabolome and phenotype of melanoma cells.
    J Invest Dermatol. 2019 Jun 20. pii: S0022-202X(19)31782.
    PubMed     Text format     Abstract available


    J Surg Oncol

  12. O'NEILL CH, Scoggins CR
    Melanoma.
    J Surg Oncol. 2019 Jun 27. doi: 10.1002/jso.25604.
    PubMed     Text format     Abstract available


    Melanoma Res

  13. MAIEZZA S, Greliak A, Rached HA, Mortier L, et al
    Exacerbation of skin psoriasis when associating an MEK inhibitor with anti-PD1 immunotherapy for metastatic melanoma.
    Melanoma Res. 2019;29:447-448.
    PubMed     Text format    

  14. MARCE D, Cornillier H, Denis C, Jonville-Bera AP, et al
    Partial response of metastatic melanoma to BRAF-inhibitor-monotherapy in a pregnant patient with no fetal toxicity.
    Melanoma Res. 2019;29:446-447.
    PubMed     Text format    

  15. RAYNER JE, McMeniman EK, Duffy DL, De'Ambrosis B, et al
    IRF4 rs12203592*T/T genotype is associated with nodular melanoma.
    Melanoma Res. 2019;29:445-446.
    PubMed     Text format    

  16. KOHLMANN J, Kirsten H, Simon JC, Ziemer M, et al
    Refined common terminology criteria for adverse events criteria - respective systemic melanoma therapy.
    Melanoma Res. 2019;29:444-445.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: